Form D · Biotechnology

Accufix Holdings, Inc.

West Haven, CT · CIK 0001827801

Offering snapshot reported Oct 3, 2022 · SEC filing

Reported sold
$3.65M
Offering amount: $3.93M
Investors reported
34
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Sep 29, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 3, 2022Initial$3,647,629No comparison34SEC filing
Aug 18, 2021Initial$425,000No comparison7SEC filing
Oct 15, 2020Initial$110,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-460562

Source: Form D, filed Oct 3, 2022. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
John Brown Director
John Evans Director, Executive
William Greim Director
Keith A Hamilton Director
James Lineberger Director
Michael Parisi Director
Robert Torney Director
Glenn Vitale Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
385 Main Street Suite 5
West Haven, CT, 06516